Iovance Biotherapeutics, Inc. (IOVA)

NASDAQ: IOVA · Real-Time Price · USD

8.74

-0.09 (-1.02%)

At close: Nov 4, 2026, 4:00 PM EST

8.80

+0.06 (0.69%)

After-hours: Nov 4, 2026, 7:15 PM EST

Iovance Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,959	1,084	2,255	2,081	1,009	2,995
Market Cap Growth	461.08%	-51.95%	8.40%	106.29%	-66.33%	-55.99%
Enterprise Value	3,707	835	1,937	1,799	729	2,491
Last Close Price	8.70	2.73	7.40	8.13	6.39	19.09

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	12.13	4.11	13.75	1749.89	-	-
PB Ratio	5.35	1.55	3.18	3.56	2.02	4.82
P/TBV Ratio	8.35	2.59	5.27	5.86	2.02	4.82

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	11.35	3.17	11.81	1512.80	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.06	0.07	0.08	0.13	0.17	0.12
Net Debt / Equity Ratio	-0.34	-0.35	-0.37	-0.35	-0.77	-0.70
Net Debt / EBITDA Ratio	0.97	0.68	0.74	0.47	0.99	1.27
Net Debt / FCF Ratio	0.85	0.74	0.73	0.53	1.23	1.63
Asset Turnover	0.36	0.29	0.19	0.00	-	-
Inventory Turnover	3.18	3.36	3.01	-	-	-
Quick Ratio	3.74	2.74	3.21	2.54	5.16	5.66
Current Ratio	4.35	3.20	3.74	2.79	5.24	5.70
Return on Equity (ROE)	-40.36%	-55.50%	-57.48%	-81.91%	-70.61%	-53.55%
Return on Assets (ROA)	-20.31%	-27.30%	-29.22%	-39.86%	-34.59%	-27.71%
Return on Capital Employed (ROCE)	-36.60%	-51.40%	-50.20%	-68.70%	-69.70%	-49.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-8.08%	-36.08%	-16.50%	-21.34%	-39.25%	-11.43%
FCF Yield	-7.52%	-31.03%	-16.14%	-18.46%	-31.05%	-8.87%
Buyback Yield / Dilution	-29.61%	-23.28%	-23.28%	-47.64%	-3.82%	-10.92%

SEC Filings: 10-K · 10-Q